Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (Sandoz Inc)
The FDA approved a generic version of Carvedilol from Sandoz Inc (ANDA) for multiple cardiovascular indications, including hypertension, hea…
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved an original application for carvedilol generic by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (Aurobindo Pharma Limited)
FDA approves the original ANDA for carvedilol by Aurobindo Pharma Limited, authorizing a generic version of carvedilol. The approval covers …
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved the original application for a generic carvedilol tablet from Unichem Pharmaceuticals (USA), Inc., expanding access to carvedil…
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva’s generic carvedilol under an Original Application (ANDA) for a generic version, expanding available generic options f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-09-03Clinical Trial Update: Vescell(TM) for the Treatment of Patients With Severe Anginal Syndrome With or Without Heart Failure [Phase 1, Phase 2]
This entry notes a Phase 1/2 clinical trial evaluating Vescell for severe anginal syndrome with or without heart failure, with an unknown st…
-
CLINICAL_TRIALS research · 2007-08-31Clinical Trial Update: The Effect of Alfa-Adrenergic Receptor Blockade on Insulin-Stimulated Forearm Glucose Uptake and Metabolism in Chronic Heart Failure [NA]
This clinical trial update examines the effects of alpha-adrenergic receptor blockade on insulin-stimulated forearm glucose uptake and metab…
-
CLINICAL_TRIALS trial_result · 2007-08-31Clinical Trial Update: ACPs Combined With CABG in Patients With CHF [Phase 1]
Phase 1 clinical trial update evaluating ACPs in combination with coronary artery bypass grafting for patients with congestive heart failure…
-
CLINICAL_TRIALS research · 2007-08-21Clinical Trial Update: The Cardiovascular Genetic and Therapeutic Implications of Muscular Dystrophy
This clinical trial update discusses cardiovascular genetic involvement in muscular dystrophy and its implications for dilated cardiomyopath…
-
CLINICAL_TRIALS trial_result · 2007-08-21Clinical Trial Update: Experimental Prospective Study on the Effectiveness and Efficiency of the Implementation of Clinical Pathways [NA]
This clinical trial update notes the completion of an experimental prospective study evaluating the effectiveness and efficiency of implemen…
-
FDA approval · 2007-08-09FDA Approved: FUROSEMIDE — Supplemental Application (Solco Healthcare LLC)
FDA approved a supplemental application for furosemide submitted by Solco Healthcare LLC.
-
CLINICAL_TRIALS trial_result · 2007-08-09Clinical Trial Update: REBEAT Resynchronisation and Beta-Blocker European Trial [Phase 4]
The Phase 4 REBEAT trial evaluating resynchronisation therapy in combination with beta-blocker treatment for heart failure has been terminat…
-
FDA approval · 2007-08-06FDA Approved: DIURIL — Supplemental Application (Salix Pharmaceuticals, Inc)
The FDA approved a supplemental application for Salix's Diuril (chlorothiazide), approving changes to its labeling as part of the supplement…
-
FDA approval · 2007-08-03FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved Waylis Therapeutics LLC's supplemental application for COREG CR, the extended-release formulation of carvedilol phosphate.
-
CLINICAL_TRIALS trial_result · 2007-08-03Clinical Trial Update: A Clinical Study Assessing the Potential of Piboserod for the Treatment of Heart Failure [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating piboserod for the treatment of heart failure.
-
CLINICAL_TRIALS trial_result · 2007-08-02Clinical Trial Update: The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive Heart Failure Patients [NA]
A terminated clinical trial evaluated whether D-ribose supplementation affects BNP levels in patients with heart failure. The sponsor was Va…
-
CLINICAL_TRIALS trial_result · 2007-08-01Clinical Trial Update: Impact of Exercise Training on Exercise Capacity in Patients With Severe Chronic Heart Failure [Phase 2]
This Phase 2 trial assesses whether a structured exercise training program improves exercise capacity in patients with severe chronic heart …
-
CLINICAL_TRIALS trial_result · 2007-08-01Clinical Trial Update: Impact of Rosuvastatin on Endothelial Function and Inflammation in Patients With Chronic Heart Failure [Phase 2]
Phase 2 trial by the University of Leipzig assessed rosuvastatin’s effects on endothelial function and inflammation in patients with chronic…
-
CLINICAL_TRIALS research · 2007-08-01Clinical Trial Update: Can a Modified Fat Diet With Low Glycaemic Load Improve Insulin Sensitivity and Inflammatory Mediators in Overweight People With Chronic Heart Failure? [Phase 1]
A Phase 1 clinical trial is exploring whether a modified fat diet with a low glycemic load can improve insulin sensitivity and inflammatory …
-
CLINICAL_TRIALS trial_result · 2007-07-20Clinical Trial Update: A Long-Term Prospective Randomized Controlled Study Using Repetitive Education at Six-Month Intervals and Monitoring for Adherence in Heart Failure Outpatients - The REMADHE Study [Phase 3]
The REMADHE Phase 3 trial is a long-term randomized study evaluating repetitive education every six months with adherence monitoring in hear…
-
FDA approval · 2007-07-20FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for HYDROCHLOROTHIAZIDE from Aurobindo Pharma Limited, approving a generic hydrochlorothiazide product…
-
FDA approval · 2007-07-16FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for COREG CR (carvedilol phosphate) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2007-06-29FDA Approved: FUROSEMIDE — Supplemental Application (Leading Pharma, LLC)
FDA approves a supplemental application for furosemide submitted by Leading Pharma, LLC.
-
CLINICAL_TRIALS research · 2007-06-29Clinical Trial Update: Role of Left Ventricular Pacing Site [NA]
This entry reports an update on a clinical trial investigating how the left ventricular pacing site affects outcomes in heart failure and re…
-
CLINICAL_TRIALS trial_result · 2007-06-26Clinical Trial Update: Correlation Research Study: IQ2, NcIQ and IQ101 [Phase 1]
Phase 1 clinical trial update for IQ2, NcIQ and IQ101 sponsored by Noninvasive Medical Technologies, Inc.; study lists Heart Failure, Dyspne…